Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Abeles

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Arthritis Care & Research|February 1, 2020
Not positive about antinuclear antibody-negative lupus: comment on the article by Choi et alAryeh M Abeles
Arthritis and Rheumatism|April 11, 2012
The need to compare rilonacept against active treatment for prevention of gout flares: comment on the article by Schumacher et alAryeh M Abeles
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Lesinurad in Combination With Allopurinol: Risk Without Reward? Comment on the Article by Saag et alAryeh M Abeles
Arthritis Care & Research|July 24, 2020
Is it Time to Sharpen Our Tools? Comment on the Article by Barber et alAryeh M Abeles
Arthritis Research & Therapy|August 22, 2014
PEG-ing down (and preventing?) the cause of pegloticase failureAryeh M Abeles
Arthritis and Rheumatism|October 23, 2010
Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et alAryeh M Abeles
Current Rheumatology Reports|March 6, 2015
Hyperuricemia, gout, and cardiovascular disease: an updateAryeh M Abeles
The New England Journal of Medicine|April 19, 2013
The bystander effect in medical careAryeh M Abeles
The Journal of Rheumatology|May 3, 2013
Five-year data from the REFLEX study: a different interpretationAryeh M Abeles
The Journal of Rheumatology|March 3, 2012
Febuxostat hypersensitivityAryeh M Abeles
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Arthritis Care & Research|February 1, 2020
Not positive about antinuclear antibody-negative lupus: comment on the article by Choi et alAryeh M Abeles
Arthritis and Rheumatism|April 11, 2012
The need to compare rilonacept against active treatment for prevention of gout flares: comment on the article by Schumacher et alAryeh M Abeles
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
Lesinurad in Combination With Allopurinol: Risk Without Reward? Comment on the Article by Saag et alAryeh M Abeles
Arthritis Care & Research|July 24, 2020
Is it Time to Sharpen Our Tools? Comment on the Article by Barber et alAryeh M Abeles
Arthritis Research & Therapy|August 22, 2014
PEG-ing down (and preventing?) the cause of pegloticase failureAryeh M Abeles
Arthritis and Rheumatism|October 23, 2010
Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et alAryeh M Abeles
Current Rheumatology Reports|March 6, 2015
Hyperuricemia, gout, and cardiovascular disease: an updateAryeh M Abeles
The New England Journal of Medicine|April 19, 2013
The bystander effect in medical careAryeh M Abeles
The Journal of Rheumatology|May 3, 2013
Five-year data from the REFLEX study: a different interpretationAryeh M Abeles
The Journal of Rheumatology|March 3, 2012
Febuxostat hypersensitivityAryeh M Abeles
Pageof 13